BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 2431494)

  • 1. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
    Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
    Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase.
    Morrison HM; Kramps JA; Afford SC; Burnett D; Dijkman JH; Stockley RA
    Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile.
    Morrison HM; Kramps JA; Burnett D; Stockley RA
    Clin Sci (Lond); 1987 Mar; 72(3):373-81. PubMed ID: 2434283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
    Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
    Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of elastase inhibitory activity of alpha 1-proteinase inhibitor and bronchial antileukoprotease: different results using insoluble elastin or synthetic low molecular weight substrates.
    Kramps JA; Morrison HM; Burnett D; Dijkman JH; Stockley RA
    Scand J Clin Lab Invest; 1987 Jun; 47(4):405-10. PubMed ID: 2440098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of granulocyte proteases with inhibitors in pulmonary diseases.
    Ohlsson K; Fryksmark U; Ohlsson M; Tegner H
    Adv Exp Med Biol; 1984; 167():299-312. PubMed ID: 6201045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
    Goldstein W; Döring G
    Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the interaction between leukocyte elastase, antileukoproteinase and the plasma proteinase inhibitors alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
    Fryksmark U; Ohlsson K; Rosengren M; Tegner H
    Hoppe Seylers Z Physiol Chem; 1983 Jul; 364(7):793-800. PubMed ID: 6194094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.
    Ohlsson K; Tegner H
    Eur J Clin Invest; 1975 Jun; 5(3):221-7. PubMed ID: 50236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory capacity of alpha 1 antitrypsin in lung secretions: variability and the effect of drugs.
    Morrison HM; Afford SC; Stockley RA
    Thorax; 1984 Jul; 39(7):510-6. PubMed ID: 6611602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term substitution in homozygous alpha 1-antitrypsin deficiency. Effect of the proteinase-antiproteinase equilibrium in plasma and sputum].
    Braun J; Welle S; van Wees J; Winterhoff R; Wood WG; Dalhoff K; Wiessmann KJ
    Dtsch Med Wochenschr; 1990 Jun; 115(23):889-94. PubMed ID: 2191843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1.
    Chan SC; Shum DK; Ip MS
    Am J Respir Crit Care Med; 2003 Jul; 168(2):192-8. PubMed ID: 12702549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
    Stockley RA; Morrison HM; Smith S; Tetley T
    Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of assay conditions on the measurement of anti-elastase function in lung secretions.
    Morrison HM; Kramps JA; Afford SC; Burnett D; Stockley RA
    Clin Chim Acta; 1987 Jan; 162(2):165-74. PubMed ID: 3644704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.
    Stockley RA; Burnett D
    Bull Eur Physiopathol Respir; 1980; 16 Suppl():261-72. PubMed ID: 6164421
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro effect of a mucolytic thiol agent on the activity of polymorphonuclear leucocyte elastase and antileucoprotease.
    Stolk J; Kramps JA; Dijkman JH
    Thorax; 1986 Nov; 41(11):840-5. PubMed ID: 3103252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of the inhibition of free and elastin-bound human pancreatic elastase by alpha 1-proteinase inhibitor and alpha 2-macroglobulin.
    Laurent P; Bieth JG
    Biochim Biophys Acta; 1989 Feb; 994(3):285-8. PubMed ID: 2465784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of concentrations of two proteinase inhibitors, porcine pancreatic elastase inhibitory capacity, and cell profiles in sequential bronchoalveolar lavage samples.
    Morrison HM; Kramps JA; Dijkman JH; Stockley RA
    Thorax; 1986 Jun; 41(6):435-41. PubMed ID: 3491440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.
    Wiggins J; Elliott JA; Stevenson RD; Stockley RA
    Thorax; 1982 Sep; 37(9):652-6. PubMed ID: 6984237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease.
    Kramps JA; van Twisk C; Klasen EC; Dijkman JH
    Clin Sci (Lond); 1988 Jul; 75(1):53-62. PubMed ID: 2842104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.